Injection Significantly Reduces in Choroidal Melanoma Tumor Growth
Three weekly doses of intravitreal AU-011 led to a significant reduction of tumor growth after a year of treatment.
Choroid
Biosimilar SB11 On Par with Ranibizumab, Phase III Trial Shows
In a 52-week phase III trial, biosimilar SB11 proved on par with ranibizumab, researchers say.
Vitrectomy Changes Some Patients’ Response to Anti-VEGF Treatment
In nonvitrectomized eyes, choriocapillaris blood flow improves with intravitreal anti-VEGF injections for patients with DME.
Patients With Migraines Have Thinner Retinal Nerve Fiber Layers, Reduced Choroidal and Luminal Areas
Choroidal vascularity index, and RNFL thickness in all quadrants except nasal were significantly reduced in study participants with migraine.
Uneventful Cataract Surgery Does Not Change Choroidal, Foveal Thicknesses
The research shows cataract removal had a temporary positive effect on CT, and no effect on FT.
Subretinal Drusenoid Deposit-Like Lesions Linked to Choroidal Ischemia
The finding was seen in patients with pre-eclampsia and malignant hypertension.
Brolucizumab Shows Strong Visual Gains for Patients With Polypoidal Choroidal Vasculopathy
Study shows BCVA gains and fluid resolution in eyes treated with the anti-VEGF agent.
Study Hones OCT-A Technique for Imaging Choriocapillaris
Balance between tissue absorbance and reflectivity may reach optimal balance around 29 µm to 49 µm below the RPE.
Hemodialysis May Affect Peripapillary Choroidal Thickness
Researchers use swept-source OCT imaging to evaluate the effect of hemodialysis on ophthalmologic parameters in patients with end-stage kidney disease.
COVID-19 May Temporarily Reduce Choroidal Thickness
Subfoveal choroidal thickness significantly decreased at the early postinfectious period compared with healthy patients, the study shows.
- Loading...
Loading...
Next post in Systemic Ophthalmology
Loading... 
Loading...